Our goal is not to be just one of the largest pharmaceutical companies, but also to be one of the fastest growing,

Remarkably, for the first 18 months there was no difference so it was consistent with all our other data and at 18 months the risk started to build and we saw the data, we withdrew the drug,

[In response to a question, he said it was impossible to give] any reliable estimate ... All those estimates are just speculation.

subject to market conditions.

Large pharmaceutical companies have grossly bid up valuations.

Japan has one of the largest concentrations of multinational companies in the world. It's an extraordinary growth opportunity for all three companies and it is essential that the global venture have a strong distributor in this key market.